NO177962C - Analogifremgangsmåte for fremstilling av terapeutisk aktive 1-oxa-2-oxo-8-azaspiro[4,5Ådecan-derivater - Google Patents

Analogifremgangsmåte for fremstilling av terapeutisk aktive 1-oxa-2-oxo-8-azaspiro[4,5Ådecan-derivater

Info

Publication number
NO177962C
NO177962C NO903512A NO903512A NO177962C NO 177962 C NO177962 C NO 177962C NO 903512 A NO903512 A NO 903512A NO 903512 A NO903512 A NO 903512A NO 177962 C NO177962 C NO 177962C
Authority
NO
Norway
Prior art keywords
group
alkyl
halogen atoms
alkoxy
oxa
Prior art date
Application number
NO903512A
Other languages
English (en)
Norwegian (no)
Other versions
NO903512L (no
NO177962B (no
NO903512D0 (no
Inventor
Edit Toth
Jozsef Torley
Laszlo Szporny
Bela Kiss
Egon Karpati
Eva Palosi
Dora Groo
Istvan Laszlovszky
Zsolt Szombathelyi
Adam Sarkadi
Aniko Gere
Katalin Csomor
Mihaly Bodo
Judit Laszy
Zsolt Szentirmay
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of NO903512D0 publication Critical patent/NO903512D0/no
Publication of NO903512L publication Critical patent/NO903512L/no
Publication of NO177962B publication Critical patent/NO177962B/no
Publication of NO177962C publication Critical patent/NO177962C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
NO903512A 1989-08-10 1990-08-09 Analogifremgangsmåte for fremstilling av terapeutisk aktive 1-oxa-2-oxo-8-azaspiro[4,5Ådecan-derivater NO177962C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU894095A HU204530B (en) 1989-08-10 1989-08-10 Process for producing new 1-oxa-2-oxo-8-aza-spiro(4,5)decane derivatives and pharmaceutical compositions containing them
SG96294A SG96294G (en) 1989-08-10 1994-07-16 1-oxa-2-oxo-8-azaspiro[4,5] decane derivatives, processes for their preparation and pharmaceutical compositions thereof

Publications (4)

Publication Number Publication Date
NO903512D0 NO903512D0 (no) 1990-08-09
NO903512L NO903512L (no) 1991-02-11
NO177962B NO177962B (no) 1995-09-18
NO177962C true NO177962C (no) 1995-12-27

Family

ID=26317733

Family Applications (1)

Application Number Title Priority Date Filing Date
NO903512A NO177962C (no) 1989-08-10 1990-08-09 Analogifremgangsmåte for fremstilling av terapeutisk aktive 1-oxa-2-oxo-8-azaspiro[4,5Ådecan-derivater

Country Status (23)

Country Link
US (1) US5118687A (bg)
EP (1) EP0414421B1 (bg)
JP (1) JPH0749431B2 (bg)
KR (1) KR940006635B1 (bg)
AT (1) ATE103920T1 (bg)
AU (1) AU622039B2 (bg)
BG (1) BG60436B2 (bg)
DD (1) DD299429A5 (bg)
DE (1) DE69007904T2 (bg)
DK (1) DK0414421T3 (bg)
ES (1) ES2052180T3 (bg)
FI (1) FI93455C (bg)
HK (1) HK145994A (bg)
HR (1) HRP920778A2 (bg)
HU (2) HU204530B (bg)
IE (1) IE64911B1 (bg)
IL (1) IL95320A (bg)
NO (1) NO177962C (bg)
NZ (1) NZ234848A (bg)
PL (3) PL163370B1 (bg)
SG (1) SG96294G (bg)
SI (1) SI9011538A (bg)
ZA (1) ZA906302B (bg)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU150489A (sh) * 1989-08-10 1992-12-21 W.L. Gore & Co. Gmbh. Uređaj za ispitivanje odevnih predmeta na nepromočivost
WO2001028602A1 (en) * 1999-10-15 2001-04-26 Genetics Institute, Inc. Formulations of hyaluronic acid for delivery of osteogenic proteins
KR20020091462A (ko) * 2001-05-30 2002-12-06 삼성광주전자 주식회사 원료 굳음 방지기능을 갖는 자동판매기 및 그 제어방법
GB201416346D0 (en) * 2014-09-16 2014-10-29 Shire Internat Gmbh Spirocyclic derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR96352E (fr) * 1967-12-29 1972-06-16 Science Union & Cie Nouveaux dérives du spiro (4,5) decane et leur procédé de préparation.
BE790675A (fr) * 1971-10-29 1973-04-27 Science Union & Cie Nouveaux derives de l'oxa-1 diaza-3,8 spiro (4,5) decane
EP0189370A3 (de) * 1985-01-16 1988-01-27 Sandoz Ag Spiro-dioxolane, -dithiolane und -oxothiolane
HU204529B (en) * 1989-08-10 1992-01-28 Richter Gedeon Vegyeszet Process for producing new 1-oxa-2-oxo-8-aza-spiro(4,5)decane derivatives and pharmaceutical compositions containing them
KR940003491B1 (ko) * 1989-08-10 1994-04-23 리히터 게데온 베기에스제티 기아르 알.티 4,4-이중 치환된 피페리딘 유도체와 그 제조방법 및 상기 화합물을 함유하는 약제학적 조성물

Also Published As

Publication number Publication date
AU622039B2 (en) 1992-03-26
HK145994A (en) 1994-12-30
EP0414421A3 (en) 1991-07-24
DD299429A5 (de) 1992-04-16
HU204530B (en) 1992-01-28
NO903512L (no) 1991-02-11
IE902884A1 (en) 1991-02-27
ZA906302B (en) 1991-06-26
PL286440A1 (en) 1992-01-27
HU210072A9 (en) 1995-02-28
IL95320A0 (en) 1991-06-30
FI93455B (fi) 1994-12-30
JPH0749431B2 (ja) 1995-05-31
DK0414421T3 (da) 1994-05-16
FI903972A0 (fi) 1990-08-10
PL291701A1 (en) 1992-05-04
PL163370B1 (pl) 1994-03-31
US5118687A (en) 1992-06-02
NZ234848A (en) 1992-03-26
DE69007904T2 (de) 1994-07-21
AU6080790A (en) 1991-02-14
KR910004632A (ko) 1991-03-29
IE64911B1 (en) 1995-09-20
PL163593B1 (en) 1994-04-29
SI9011538A (sl) 1998-08-31
ATE103920T1 (de) 1994-04-15
EP0414421B1 (en) 1994-04-06
PL163431B1 (pl) 1994-03-31
NO177962B (no) 1995-09-18
DE69007904D1 (de) 1994-05-11
ES2052180T3 (es) 1994-07-01
HRP920778A2 (en) 1998-02-28
HUT55786A (en) 1991-06-28
PL291702A1 (en) 1992-05-04
IL95320A (en) 1994-01-25
SG96294G (en) 1994-10-28
JPH0377884A (ja) 1991-04-03
NO903512D0 (no) 1990-08-09
FI93455C (fi) 1995-04-10
EP0414421A2 (en) 1991-02-27
BG60436B2 (bg) 1995-03-31
KR940006635B1 (ko) 1994-07-23

Similar Documents

Publication Publication Date Title
DE3873612D1 (de) Dithioacetal-verbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
HU906402D0 (en) Process for producing tricyclic carbapeneme derivatives an pharmaceutical preparatives containing these compounds as active substance
DK0414422T3 (da) 2-Oxo-1-oxa-8-azaspiro(4,5)decan-derivater, fremgangsmåder til deres fremstilling samt præparater deraf
NO177962C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 1-oxa-2-oxo-8-azaspiro[4,5Ådecan-derivater
NO171362C (no) Analogifremgangsmaate for fremstilling av nye aralkylaminforbindelser og deres salter
FI903973A0 (fi) Nya 2-oxo-1-oxa-8-azaspiro/4,5/ dekanderivat, farmaceutiska kompositioner innehaollande dessa och foerfarande foer framstaellning av dessa.
FI903511A0 (fi) Pyrrolo (2,1-b) tiazolderivat.